Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2Breast 2Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 294Neoplasms 221Prostatic Neoplasms 178Colorectal Neoplasms 125Lung Neoplasms 121Carcinoma, Non-Small-Cell Lung 108Leukemia, Myeloid, Acute 92Pancreatic Neoplasms 84Multiple Myeloma 76Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Squamous Cell Carcinoma of Head and Neck 63Carcinoma, Hepatocellular 62Head and Neck Neoplasms 60Glioblastoma 60Brain Neoplasms 58Neoplasm Metastasis 54Melanoma 51Uterine Cervical Neoplasms 47Carcinoma, Renal Cell 46Rectal Neoplasms 45Stomach Neoplasms 44Ovarian Neoplasms 44Hematologic Neoplasms 44Myelodysplastic Syndromes 39Triple Negative Breast Neoplasms 38Motor Activity 38Esophageal Neoplasms 36Colonic Neoplasms 36Urinary Bladder Neoplasms 35Recurrence 34

Interventions

Tretinoin 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1talazoparib 1sarilumab 1pexidartinib 1pertuzumab 1pembrolizumab 1patritumab 1olaparib 1niraparib 1neratinib 1ganitumab 1durvalumab 1dostarlimab 1cemiplimab 1abemaciclib 1Trastuzumab 1Standard of Care 1STA 9090 1SGN-LIV1A 1Paclitaxel 1MK 2206 1Letrozole 1Lasofoxifene 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pathologic Complete Response × 30 days × Clear all
NCT07586813 2026-05-14

N01-A-PICIT-GI

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

NCT01042379 2026-05-06

I-SPY

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
5,000 enrolled
BreastSarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡